A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies

Exclusion Criteria

• •1. Subject is pregnant or plans to become pregnant or actively lactating/nursing
• •2. Hypersensitivity to any ingredient in the study product
• •3. Initial laboratory values as determined by the principal investigator to be clinically significant
• •4. A substance abuse history within the last five years
• •5. Any diseases or conditions that may interfere with the conduct of the study or interpretation of the study results
• •6. .Close affiliation with the investigational site (e.g., a close relative of the investigator), dependent person (employee or student of investigational site, or sponsor's staff)
• •7. Currently enrolled in another investigational clinical study
• •8. A known history of severe depression or psychiatric disorders or active suicidal ideation
• •9. Inability or unwillingness to cooperate with the study procedures for any reasons